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Background: Bai Ku Yao is a special subgroup of the Yao minority in China. The present study was undertaken to
detect the association of rs5888 single nucleotide polymorphism (SNP) in the scavenger receptor class B type 1
(SCARB1) gene and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han
populations.
Methods: A total of 598 subjects of Bai Ku Yao and 585 subjects of Han Chinese were randomly selected from our
stratified randomized cluster samples. Genotypes of the SCARB1 rs5888 SNP were determined by polymerase chain
reaction and restriction fragment length polymorphism combined with gel electrophoresis, and then confirmed by
direct sequencing.
Results: The levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein
cholesterol (LDL-C), apolipoprotein (Apo) AI were lower but ApoB was higher in Bai Ku Yao than in Han (P< 0.05-
0.001). The frequencies of C and T alleles were 78.3% and 21.7% in Bai Ku Yao, and 73.7% and 26.3% in Han
(P< 0.01); respectively. The frequencies of CC, CT and TT genotypes were 60.0%, 36.6% and 3.4% in Bai Ku Yao, and
54.2%, 39.0% and 6.8% in Han (P< 0.01); respectively. The subjects with TT genotype in both ethnic groups had
lower HDL-C and ApoAI levels than the subjects with CC or CT genotype (P< 0.05 for all). Subgroup analyses
showed that the subjects with TT genotype in Bai Ku Yao had lower HDL-C and ApoAI levels in males than the
subjects with CC or CT genotype (P< 0.05 for all), and the T allele carriers had higher TC, LDL-C and ApoB levels in
females than the T allele noncarriers (P< 0.05 for all). The participants with TT genotype in Han also had a lower
tendency of HDL-C and ApoAI levels in males than the participants with CC or CT genotype, but the difference did
not reach statistically significant (P= 0.063 and P= 0.086; respectively). The association of serum HDL-C and ApoAI
levels and genotypes was confirmed by the multiple linear regression analysis in both ethnic groups. Serum lipid
parameters were also correlated with several environmental factors.
Conclusions: The differences in serum lipid levels between the two ethnic groups might partially attribute to the
differences in the SCARB1 rs5888 SNP and several environmental factors.* Correspondence: yinruixing@yahoo.com.cn
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Coronary heart disease (CHD) remains a major cause of
worldwide morbidity and mortality despite therapeutic
advances that control many risk factors such as low-
density lipoprotein cholesterol (LDL-C) to levels lower
than previously possible [1]. Plasma high-density lipo-
protein cholesterol (HDL-C) levels are considered as a
major determinant of susceptibility to coronary athero-
sclerosis in the general population [2,3]. A low plasma
HDL-C level is the most common lipid abnormality
found in families with premature coronary atheroscler-
osis [2]. Epidemiological studies showed that plasma
HDL-C levels are inversely associated with the risk of
CHD: an increase of 1 mg/dl of HDL-C levels is asso-
ciated with a 2% to 3% decrease of the risk for CHD
[4,5]. The metabolism of HDL-C is complex, with many
factors influencing its circulating plasma levels, both
genetic and non-genetic. It has been reported that vari-
ation in HDL-C levels is at least 50% genetically deter-
mined [6]. A number of variants in candidate genes have
been implicated in the regulation of plasma HDL-C
levels [7,8].
The scavenger receptor class B type 1 (SCARB1) is the
HDL receptor which binds HDL-C with high affinity. It
is expressed primarily in liver and nonplacental steroido-
genic tissues and mediates selective cholesterol uptake
of HDL by a mechanism distinct from the classic LDL-C
receptor pathway, and plays an important role in reverse
cholesterol translation (RCT) [9]. In mouse models,
studies have clearly demonstrated the crucial role of
SCARB1 gene in HDL-C metabolism. Hepatic overex-
pression of SCARB1 markedly reduced HDL-C and apo-
lipoprotein (Apo) AI levels, and increased biliary
cholesterol [10]. In contrast, targeted disruption of the
SCARB1 gene in mice reduced selective uptake of chol-
esterol ester from HDL into the liver and significantly
increased plasma HDL-C [11,12]. As a multilipoprotein
receptor, SCARB1 also regulates the concentrations of
LDL-C and very-low-density lipoprotein (VLDL-C)
[13,14]. Mice with hepatic overexpression of SCARB1
have lower concentrations of VLDL and LDL [15,16].
Conversely, mice with attenuated expression of SCARB1
display elevated concentration of LDL-C [17]. Despite
the obvious functional evidence for an influence of
SCARB1 on altered serum lipid profile in animal models,
it remains to be determined whether this receptor has
an equally important function in humans.
The human SCARB1 gene encodes a 509 amino acid
protein with a molecular weight of 82 kDa [13] and
located on chromosome 12q24, a region showing signifi-
cant linkage to plasma HDL-C levels [18]. Previous stud-
ies have investigated the relationship between variants in
the SCARB1 gene and alterations on serum lipid profile
in diverse human populations [19-24]. The singlenucleotide polymorphism (SNP) of rs5888, a“C” to “T”
substitution at amino acid 350 in exon 8, has been asso-
ciated with the lipid concentrations of HDL-C
[19,21,23,24] and LDL-C [20,21,23]. The C allelic fre-
quency of SCARB1 rs5888 was varied from 40% to 60%
in white population [19-23]. However, in Korean sub-
jects the C allelic frequency of SCARB1 rs5888 was 67%
in control and 83% in CHD [24]. These studies suggest
that the polymorphism of SCARB1 rs5888 might be dif-
ferent among diverse ethnic groups. Thus, the SCARB1
rs5888 polymorphism in other racial groups still needs
to be determined [24].
China is a multi-ethnic country. There are 56 ethnic
groups. Han is the largest ethnic group and Yao is the
eleventh largest minority among the 55 minority groups
according to the population size. Bai Ku Yao (White-
trouser Yao), an isolated branch of the Yao minority, is
named so because all of the men wear white knee-length
knickerbockers. The population size is about 30000. Be-
cause of isolation from the other ethnic groups, the spe-
cial customs and cultures including their clothing, intra-
ethnic marriages, dietary habits, and corn wine and rum
intakes are still completely preserved to the present day.
They are currently in a transitional period from the ma-
triarchal society to patriarchal society. In several previ-
ous epidemiological studies, we showed that several
serum lipid phenotypes were lower in Bai Ku Yao than
in Han Chinese from the same region [25,26]. This eth-
nic difference in serum lipid profiles is still not well
known. We hypothesized that some genetic factors may
be different between the two ethnic groups. The SNP of
rs5888 in SCARB1 gene had not been discussed in the
Chinese population. The aim of the present study was to
determine the association of SCARB1 rs5888 SNP and
several environmental factors with serum lipid levels in
the Guangxi Bai Ku Yao and Han populations.
Materials and methods
Study population
This study included 598 subjects of Bai Ku Yao who res-
ide in Lihu and Baxu villages in Nandan County,
Guangxi Zhuang Autonomous Region, People’s Republic
of China and 585 subjects of Han Chinese reside in the
same villages. The subjects of Bai Ku Yao consisted of
286 (47.8%) males and 312 (52.2%) females, ranged in
age from 16 to 80 years, with a mean age of
40.22 ± 15.18 years. The subjects of Han consisted of 277
(47.4%) males and 308 (52.6%) females, aged 16–92 years,
with a mean age of 41.87 ± 16.35 years. All of the sub-
jects were randomly selected from our previous stratified
randomized cluster samples [25,26]. The study subjects
were healthy rural agricultural workers and without evi-
dence of any chronic illness, including hepatic, renal, or
thyroid. The participants with a history of heart attack
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diabetes have been excluded. The participants were not
on any lipid-lowering treatment. The present study was
approved by the Ethics Committee of the First Affiliated
Hospital, Guangxi Medical University. Informed consent
was obtained from all subjects after they received a full
explanation of the study.
Epidemiological survey
The survey was carried out using internationally stan-
dardized methods [27]. Information on demographics,
socioeconomic status, and lifestyle factors were collected
with standardized questionnaires. The alcohol informa-
tion included questions about the number of liangs
(about 50 g) of rice wine, corn wine, rum, beer, or liquor
consumed during the preceding 12 months. At the phys-
ical examination, several parameters such as height,
weight, and waist circumference were measured. Sitting
blood pressure was measured using a mercury sphygmo-
manometer on 3 separated intervals after the subjects
had a 5-minute rest, and the average of the three mea-
surements was used for the level of blood pressure. Body
mass index (BMI) was calculated as weight in kg divided
by the square of height in meters (kg/m2).
Biochemical analysis
Venous blood samples were obtained from all subjects
after at least 12 hours of fasting. The levels of serum
TC, triglyceride (TG), HDL-C, and LDL-C in samples
were determined by enzymatic methods with commer-
cially available kits. Serum ApoAI and ApoB levels were
detected by the immunoturbidimetric immunoassay
using a commercial kit [25,26] .
DNA amplification and genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes using the phenol-chloroform method [28].
Genotyping of the SCARB1 rs5888 SNP was performed
by polymerase chain reaction and restriction fragment
length polymorphism (PCR-RFLP). A pair of primers
was designed to introduce a HinI1 restriction site
(GACGCC) by changing a base from A to G. Forward 5'-
CCTTGTTTCTCTCCCATCCTCACTTCCTCGACGC-3',
Reverse primer 5'-CACCACCCCAGCCCACAGCAGC-3'
(Sangon, Shanghai, People’s Republic of China). Each 20 μL
PCR reaction mixture consisted of 1 μL of genomic DNA,
0.5 μL of each primer (10 pmol/L), 10 μL of 2×Taq PCR
Mastermix (constituent: 20 mM Tris–HCl, pH 8.3,
100 mM KCl, 3 mM MgCl2, 0.1 U Taq Polymerase/μL,
500 μM dNTP each; Tiangen, Beijing, People’s Republic of
China), and 8 μL of ddH2O (DNase/RNase-free). The reac-
tion mixture was subjected to denaturation at 95°C for
5 min, followed by 33 cycles at 95°C for 45 s, 71.5°C for
30 s, 72°C for 50 s, then by a final extension at 72°C for8 min. The quality of PCR products was controlled by elec-
trophoresis on 2% agarose gel and visualized with eth-
idium-bromide staining ultraviolet illumination. Then 5 μL
of amplification products were digested at 37°C overnight
with 5 U of HinI1 restriction enzyme (Fermentas Co.
Canada). After restriction enzyme digestion of the amplified
DNA, the fragments were separated by electrophoresis on
3% agarose gels stained with ethidium bromide, photo-
graphed in ultraviolet light. Genotypes were scored by an
experienced reader blinded to epidemiological data and
serum lipid levels. Six samples (CC, CT and TT genotypes
in two; respectively) detected by the PCR-RFLP were also
confirmed by direct sequencing.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoAI, ApoB levels, and the ratio of ApoAI to ApoB in
our Clinical Science Experiment Center were 3.10-5.17,
0.56-1.70, 0.91-1.81, 2.70-3.20 mmol/L, 1.00-1.78, 0.63-
1.14 g/L, and 1.00-2.50; respectively[25,26]. Hyperten-
sion was diagnosed according to the criteria of 1999
World Health Organization-International Society of
Hypertension Guidelines for the management of hyper-
tension [29]. Normal weight, overweight and obesity
were defined as a BMI< 24, 24–28, and> 28 kg/m2; re-
spectively [25,26].
Statistical analyses
Epidemiological data were recorded on a pre-designed
form and managed with Excel software. All statistical
analyses were carried out using the statistical software
package SPSS 13.0 (SPSS Inc., Chicago, Illinois). Qualita-
tive variables were expressed as raw count and percent-
age. Mean ± standard deviation was used for the
presentation of quantitative variables. Genotypic and al-
lelic frequencies were calculated by direct counting, the
Hardy-Weinberg equilibrium (HWE) was tested by chi-
square, using the observed genotypic frequencies
obtained from the data and expected genotypic fre-
quency obtained using the HWE. A chi-square analysis
was also used to evaluate the difference in genotype dis-
tribution and sex ratio between the groups. The differ-
ence in general characteristics between Bai Ku Yao and
Han was tested by the Student’s unpaired t-test. The as-
sociation of genotypes and serum lipid parameters was
tested by analysis of covariance (ANCOVA). Sex, age,
BMI, blood pressure, alcohol consumption, cigarette
smoking were adjusted for the statistical analysis. All sig-
nificant associations were corrected for multiple testing
by applying a Bonferroni correction. In order to evaluate
the association of serum lipid levels with genotypes
(CC= 1, CT=2, TT= 3) and several environment factors,
multiple linear regression analysis with stepwise model-
ing was also performed in the combined population of
Table 1 The general characteristics and serum lipid levels
Parameter Bai Ku Yao Han Chinese t (χ2) P
Number 598 585 – –
Male/female 286/312 277/308 0.027 0.870
Age (years) 40.22 ± 15.18 41.87 ± 16.35 −1.795 0.073
Height (cm) 152.64 ± 7.37 156.33± 7.90 −8.318 0.000
Weight (kg) 51.69 ± 7.23 54.57 ± 9.74 −5.742 0.000
Body mass index (kg/m2) 22.15 ± 2.38 22.29 ± 3.46 −0.814 0.416
Systolic blood pressure (mmHg) 119.26 ± 17.44 122.78± 18.76 −3.352 0.001
Diastolic blood pressure (mmHg) 75.46 ± 9.69 77.58 ± 11.52 −3.430 0.001
Pulse pressure (mmHg) 43.80 ± 13.23 45.20 ± 12.79 −1.855 0.064
Cigarette smoking [n (%)]
Nonsmoker 414 (69.2) 437 (74.7)
< 20 cigarettes/day 84 (14.0) 57 (9.7)
≥ 20 cigarettes/day 100 (16.7) 91 (15.6) 6.074 0.048
Alcohol consumption [n (%)]
Nondrinker 329 (55.0) 458 (78.3)
< 25 g/day 172 (28.8) 80 (13.7) 71.959 0.000
≥ 25 g/day 97 (16.2) 47 (8.0)
Total cholesterol (mmol/L) 4.35 ± 0.92 4.71 ± 0.99 −6.551 0.000
Triglyceride (mmol/L) 1.00 (0.65) 1.00 (0.79) −1.734 0.083
HDL-C (mmol/L) 1.67 ± 0.42 1.73 ± 0.46 −2.431 0.015
LDL-C (mmol/L) 2.57 ± 0.76 2.72 ± 0.79 −3.502 0.000
Apolipoprotein (Apo) AI (g/L) 1.31 ± 0.32 1.35 ± 0.31 −2.110 0.035
ApoB (g/L) 0.85 ± 0.23 0.82 ± 0.20 2.314 0.021
ApoAI/ApoB 1.67 ± 0.75 1.73 ± 0.53 −1.382 0.167
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. The value of triglyceride was presented as median (interquartile range). The
difference between the two ethnic groups was determined by the Wilcoxon-Mann–Whitney test.
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females; respectively. A two-tailed P value less than 0.05
was considered statistically significant.
Results
General characteristics and serum lipid levels
The general characteristics and serum lipid levels
between the Bai Ku Yao and Han populations are sum-
marized in Table 1. As comparison with the population
of Han, Bai Ku Yao has lower levels of height, weight,
systolic blood pressure, diastolic blood pressure, serum
TC, HDL-C, LDL-C, ApoAI, and higher serum ApoB
levels, percentages of subjects who consumed alcohol or
smoked cigarettes (P< 0.05-0.001). There were no sig-
nificant differences in the levels of BMI, pulse pressure,
serum TG, the ratio of ApoAI to ApoB, age structure, or
the ratio of male to female between the two ethnic
groups (P> 0.05 for all).
Results of electrophoresis and genotyping
After the genomic DNA of the samples was amplified by
PCR and imaged by 2.0% agarose gel electrophoresis, thePCR products of 218 bp nucleotide sequences could be
found in all samples (Figure 1). The genotypes identified
were named according to the presence or absence of the
enzyme restriction sites, when a C to T transversion at
amino acid 350 of the SCARB1 gene. The presence of
the cutting site indicates the C allele, while its absence
indicates the T allele (cannot be cut). Thus, the TT geno-
type is homozygote for the absence of the site (band at
218 bp), CT genotype is heterozygote for the absence
and presence of the site (bands at 218-, 187- and 31-bp),
and CC genotype is homozygote for the presence of the
site (bands at 187- and 31-bp; Figure 2). The 31 bp frag-
ment was invisible in the gel owing to its fast migration
speed.Genotypic and allelic frequencies
The genotypic and allelic frequencies of SCARB1 rs5888
SNP are shown in Table 2. The frequency of C and T
alleles was 78.3% and 21.7% in Bai Ku Yao, and 73.7%
and 26.3% in Han (P< 0.01); respectively. The frequency
of CC, CT and TT genotypes was 60.0%, 36.6% and 3.3%
Figure 1 Electrophoresis of PCR products of the samples. Lane
M, 50 bp marker ladder; lanes 1–5, samples. The 218 bp bands are
the PCR products.
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< 0.01); respectively. There was no significant difference
in the genotypic and allelic frequencies between males
and females in both ethnic groups.Results of sequencing
The results were shown as CC, CT and TT genotypes by
PCR-RFLP, the CC, CT and TT genotypes were also con-
firmed by sequencing (Figure 3); respectively.Figure 2 Genotyping of rs5888 SNP in the SCARB1 gene. Lane
M, 50 bp marker ladder; lanes 1–2, TT genotype (218 bp); lanes 3
and 4, CT genotype (218-, 187- and 31-bp); and lanes 5 and 6, CC
genotype (187- and 31-bp). The 31 bp fragment was invisible in the
gel owing to its fast migration speed.Genotypes and serum lipid levels
As shown in Table 3, the levels of HDL-C and ApoAI in
the Bai Ku Yao and Han subjects were different among
the three genotypes (P< 0.05 for all), the subjects with
TT genotype had lower serum HDL-C and ApoAI levels
than the subjects with CT or CC genotype. When ana-
lysis of covariance was stratified according to sex in both
ethnic groups, we found that the subjects with TT geno-
type in Bai Ku Yao had lower HDL-C and ApoAI levels
in males than the subjects with CC or CT genotype (P
< 0.05 for all), and the T allele carriers had higher TC,
LDL-C and ApoB levels in females than the T allele non-
carriers (P< 0.05 for all). The participants with TT geno-
type in Han also had a lower tendency of HDL-C and
ApoAI levels in males than the participants with CC or
CT genotype, but the difference did not reach statisti-
cally significant (P= 0.063 and P= 0.086; respectively).
Relative factors for serum lipid parameters
Multiple linear regression analysis showed that serum
HDL-C and ApoAI levels were correlated with geno-
types in the combined populations of Bai Ku Yao and
Han, Bai Ku Yao, and Han; respectively (P< 0.05 for all).
When multiple linear regression analysis was performed
according to sex in both ethnic groups, we found that
the levels of HDL-C and ApoAI in Bai Ku Yao were cor-
related with genotypes in males (P< 0.05 for each,
Table 4) but not in females. The levels of TC and LDL-C
in Bai Ku Yao were also associated with genotypes in
females but not in males. The levels of TG and HDL-C
in Han were correlated with genotypes in males (P
< 0.05 for each). Serum lipid parameters were also cor-
related with sex, age, BMI, alcohol consumption,
cigarette smoking, and blood pressure in both ethnic
groups (Tables 5 and 4).
Discussion
The current study shows that the levels of serum TC,
HDL-C, LDL-C, ApoAI were lower, whereas the levels
of ApoB was higher in Bai Ku Yao than in Han. There
was no significant difference in the levels of TG and the
ratio of ApoAI to ApoB between the two ethnic groups.
It is well known that dyslipidemia is a complex trait
caused by both environmental and genetic factors. Bai
Ku Yao is an isolated subgroup of the Yao minority in
China. Strict intra-ethnic marriages have been per-
formed in this population from time immemorial.
Therefore, we are confident that the hereditary charac-
teristics and genotypes of some lipid metabolism-related
genes in this population may be different from those in
Han Chinese.
In the present study, we showed that there was signifi-
cant difference in the allelic and genotypic frequencies
of SCARB1 rs5888 SNP between the two ethnic groups.
Table 2 The genotype and allele frequencies of the SCARB1 rs5888 SNP [n (%)]
Group n Genotype Allele
CC CT TT C T
Bai Ku Yao 598 359 (60.0) 219 (36.6) 20 (3.4) 937 (78.3) 259 (21.7)
Han Chinese 585 317 (54.2) 228 (39.0) 40 (6.8) 862 (73.7) 308 (26.3)
χ2 – 9.316 7.076
P – 0.009 0.008
Bai Ku Yao
Male 286 176 (61.5) 99 (34.6) 11 (3.8) 451 (78.8) 121 (21.2)
Female 312 183 (58.7) 120 (38.5) 9 (2.9) 486 (77.9) 138 (22.1)
χ2 – 1.222 0.163
P – 0.543 0.687
Han Chinese
Male 277 145 (52.3) 114 (41.2) 18 (6.5) 404 (72.9) 150 (27.1)
Female 308 172 (55.8) 114 (37.0) 22 (7.1) 458 (74.4) 158 (25.6)
χ2 – 1.060 0.306
P – 0.589 0.580
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Yao than in Han. The frequency of C allele was also
higher in Bai Ku Yao than in Han (78.3% vs 73.7%,Figure 3 A part of the nucleotide sequence of rs5888 SNP in the SCAP< 0.01). To the best of our knowledge, this is the first
study to report the association of SCARB1 rs5888 SNP
and serum lipid levels in the Bai Ku Yao population. TheRB1 gene. (A) CC genotype; (B) CT genotype; (C) TT genotype.
Table 3 The genotypes of SCARB1 rs5888 SNP and serum lipid levels
Genotype n TC (mmol/L) TG (mmol/L) HDL-C (mmol/L) LDL-C (mmol/L) ApoAI (g/L) ApoB (g/L) ApoAI/ApoB
Bai Ku Yao
CC 359 4.30 ± 0.94 0.98 (0.69) 1.66 ± 0.42a 2.54 ± 0.76 1.31 ± 0.32a 0.84 ± 0.23 1.68 ± 0.76
CT 219 4.44 ± 0.89 1.02 (0.62) 1.69 ± 0.41a 2.64 ± 0.75 1.33 ± 0.33a 0.87 ± 0.22 1.67 ± 0.72
TT 20 4.04 ± 0.96 1.10 (0.52) 1.43 ± 0.36 2.42 ± 0.88 1.14 ± 0.27 0.78 ± 0.27 1.66 ± 1.00
F – 2.770 0.388 4.001 1.625 3.878 1.871 0.023
P – 0.063 0.824 0.019 0.198 0.021 0.155 0.977
Male
CC 176 4.39 ± 1.09 1.18 (0.95) 1.70 ± 0.49a 2.54 ± 0.92 1.38 ± 0.37a 0.83 ± 0.23 1.82 ± 0.95
CT 99 4.43 ± 1.01 1.05 (0.69) 1.74 ± 0.46b 2.55 ± 0.86 1.39 ± 0.40a 0.83 ± 0.23 1.86 ± 0.92
TT 11 3.97 ± 1.07 1.25 (0.61) 1.30 ± 0.45 2.35 ± 0.99 1.10 ± 0.35 0.76 ± 0.30 1.74 ± 1.32
F – 0.985 1.822 4.743 0.253 3.769 0.559 0.117
P – 0.375 0.402 0.009 0.776 0.024 0.572 0.889
CC 176 4.39 ± 10.9 1.18 (0.95) 1.70 ± 0.49 2.54 ± 0.92 1.38 ± 0.37 0.83 ± 0.23 1.82 ± 0.95
CT + TT 110 4.38 ± 1.02 1.06(0.65) 1.70 ± 0.47 2.53 ± 0.87 1.36 ± 0.40 0.82 ± 0.24 1.85 ± 0.96
F – 0.003 −1.246 0.024 0.014 0.222 0.106 0.072
P – 0.959 0.213 0.877 0.907 0.638 0.745 0.788
Female
CC 183 4.22 ± 0.76 0.90 (0.51) 1.63 ± 0.33 2.53 ± 0.58 1.24 ± 0.25 0.84 ± 0.22 1.56 ± 0.48
CT 120 4.45 ± 0.78c 1.00 (0.61) 1.65 ± 0.35 2.72 ± 0.64c 1.27 ± 0.25 0.90 ± 0.19 1.49 ± 0.44
TT 9 4.19 ± 0.84 1.05 (0.38) 1.51 ± 0.24 2.57 ± 0.74 1.16 ± 0.16 0.84 ± 0.24 1.46 ± 0.31
F – 3.562 2.102 0.655 3.881 1.198 2.601 1.121
P – 0.030 0.350 0.520` 0.022 0.303 0.076 0.327
CC 183 4.22 ± 0.76 0.90 (0.51) 1.63 ± 0.33 2.53 ± 0.58 1.24 ± 0.25 0.84 ± 0.22 1.56 ± 0.48
CT + TT 129 4.43 ± 0.78 1.01(0.60) 1.64 ± 0.34 2.71 ± 0.65 1.26 ± 0.24 0.89 ± 0.20 1.48 ± 0.44
F – 6.103 −1.429 0.054 7.234 0.542 4.473 2.224
P – 0.014 0.153 0.817 0.008 0.462 0.035 0.137
Han Chinese
CC 317 4.73 ± 0.96 0.97 (0.82) 1.76 ± 0.49a 2.75 ± 0.76 1.36 ± 0.31a 0.82 ± 0.19 1.74 ± 0.54
CT 228 4.71 ± 1.01 1.05 (0.78) 1.72 ± 0.44a 2.73 ± 0.85 1.35 ± 0.31a 0.82 ± 0.21 1.74 ± 0.54
TT 40 4.54 ± 1.05 0.99 (0.97) 1.55 ± 0.35 2.58 ± 0.67 1.23 ± 0.21 0.81 ± 0.18 1.56 ± 0.35
F – 0.821 1.764 4.125 0.965 3.824 0.044 2.313
P – 0.441 0.414 0.017 0.381 0.022 0.957 0.100
Male
CC 145 4.73 ± 0.94 1.11 (0.89) 1.68 ± 0.54 2.74 ± 0.72 1.34 ± 0.36 0.83 ± 0.18 1.67 ± 0.50
CT 114 4.70 ± 1.07 1.13 (0.90) 1.64 ± 0.39 2.74 ± 0.91 1.32 ± 0.32 0.84 ± 0.23 1.67 ± 0.54
TT 18 4.59 ± 1.22 1.23 (1.79) 1.43 ± 0.26 2.47 ± 0.65 1.18 ± 0.18 0.83 ± 0.20 1.49 ± 0.37
F – 0.233 1.500 2.793 1.070 2.474 0.036 1.160
P – 0.793 0.472 0.063 0.344 0.086 0.965 0.315
CC 145 4.73 ± 0.94 1.11 (0.89) 1.68 ± 0.54 2.74 ± 0.72 1.34 ± 0.36 0.83 ± 0.18 1.67 ± 0.50
CT + TT 132 4.69 ± 1.09 1.15(0.94) 1.61 ± 0.38 2.71 ± 0.88 1.30 ± 0.30 0.84 ± 0.22 1.65 ± 0.52
F – 0.212 −1.071 1.746 0.139 1.216 0.041 0.124
P – 0.646 0.284 0.187 0.709 0.271 0.839 0.725
Female
CC 172 4.74 ± 0.98 0.91 (0.80) 1.83 ± 0.43 2.76 ± 0.80 1.38 ± 0.27 0.81 ± 0.19 1.80 ± 0.57
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Table 3 The genotypes of SCARB1 rs5888 SNP and serum lipid levels (Continued)
CT 114 4.69 ± 0.94 0.96 (0.60) 1.78 ± 0.48 2.70 ± 0.78 1.37 ± 0.31 0.80 ± 0.19 1.80 ± 0.53
TT 22 4.54 ± 0.91 0.94 (0.69) 1.68 ± 0.38 2.68 ± 0.69 1.29 ± 0.23 0.80 ± 0.15 1.64 ± 0.34
F – 0.559 0.914 1.343 0.373 1.139 0.115 0.937
P – 0.572 0.633 0.263 0.689 0.322 0.891 0.393
CC 172 4.74 ± 0.98 0.91 (0.80) 1.83 ± 0.43 2.76 ± 0.80 1.38 ± 0.27 0.81 ± 0.19 1.80 ± 0.57
CT + TT 136 4.66 ± 0.93 0.96(0.60) 1.76 ± 0.46 2.69 ± 0.77 1.36 ± 0.30 0.80 ± 0.18 1.77 ± 0.50
F 0.644 −0.657 1.841 0.730 0.602 0.227 0.255
P 0.423 0.511 0.176 0.394 0.439 0.634 0.614
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B. The value of TG was presented as median (interquartile range), the difference among the genotypes was determined by the Kruskal-Wallis test
or the Wilcoxon-Mann–Whitney test. a P <0.05, b P <0.01 in comparison with the TT genotype of the same ethnic group and c P <0.05 in comparison with the CC
genotype of the same ethnic group.
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http://www.lipidworld.com/content/11/1/50genotypic and allelic frequency of SCARB1 rs5888 SNP
in Han population observed in our research was also
consistent with the frequency of Han Chinese from Bei-
jing published on NCBI database (http://www.ncbi.nlm.
nih.gov/projects/SNP/snp_ref.cgi?rs=5888). Several simi-
lar researches have carried out in European and North
American populations. In a initial study in Spain popula-
tion, Acton et al. [20] determined the polymorphism of
Exon 8 (C/T) (rs5888) and showed that the frequency of
C allele was 56.22% in a general white Spanish popula-
tion. In another study, McCarthy et al. [22] reported the
frequency of C allele was 44.7% in Israeli, 60.2% in Finn
and 52.5% in Swede; respectively. In an American popu-
lation of Central European ancestry, the allele frequency
of C in the SCARB1 gene was 59.0% [19]. In a popula-
tion of Caucasian in America, the frequency of C allele
of rs5888 polymorphism in the SCARB1 gene was
51.39% in men and women [23]. In Korean subjects,
however, the frequency of the common C allele of
SCARB1 HaeIII (rs5888) was 67% in control and 83% in
CHD [24] which was similar to our study in Chinese
population. Thus, our findings, coupled with reports in
the literature, provide evidence for the prevalence of the
C allele variation of rs5888 in the SCARB1 gene may
have an ethnic specificity.
Several ethnic distinct populations have been previ-
ously reported that the T allele of SCARB1 rs5888 is cor-
related with an increase of serum HDL-C concentration
and a decrease of LDL-C concentration. In a population
of healthy Spanish, Acton et al. [20] reported that the T
allele carriers have significant lower concentration of
LDL-C than the T allele noncarriers in females but not
in males. They did not find the association of exons 8
(rs5888) variant in SCARB1 with HDL-C levels. In a
population of Caucasian in North America, Osgood
et al. [23] showed that the T allele was associated with
an increase in HDL particle size in men and women,
serum HDL-C levels in men, and a decrease in LDL-C
levels in women. In a cohort of the Amish FamilyDiabetes, Roberts et al. [19] documented that the rs5888
variant was significantly associated with higher HDL-C
level in women younger than 50 years but not in women
aged 50 years or older. In a case–control study including
137 subject with CHD and 124 age-matched controls,
the concentrations of plasma HDL-C and ApoAI varied
significantly among HaeIII (rs5888) genotypes in the
CHD patients but not in the controls, the common
genotype (CC) was associated with a lower concentra-
tions of plasma HDL-C and ApoAI [24]. Morabia et al.
[21] also found that the T allele has higher levels of
HDL-C and HDL-C/LDL-C ratio in men. Two other
studies carried out by McCarthy et al. [20,30] did not
find the single rs5888 variant was correlated with lipid
profiles, when combined with other polymorphisms in
the SCARB1 gene, the combined genotypes were asso-
ciated with TG, TG/HDL-C ratio and HDL-C in the
women. However, some researches found that the
rs5888 T allele was associated with increased levels of
TC, LDL-C and TG. In a research on subjects with
heterozygous familial hypercholesterolemia, Tai et al.
[31] found that the exon 8 (rs5888) polymorphism was
associated with increased levels of TC, VLDL-C, LDL-C
and TG. Morabia et al. [21] also showed that the geno-
type of TT had higher levels of TC and LDL-C than the
CC genotype in females.
It is well documented that an overexpression of
SCARB1 in the animal model could induce a decreased
in the levels of HDL-C, LDL-C, and ApoB [10,15] and
mice with attenuated expression of SCARB1 display ele-
vated concentrations of LDL-C as well as HDL-C
[11,12]. In human, a novel 11-base pair deletion muta-
tion in the promoter region of the SCARB1 gene
explained some of the interindividual variation in plasma
HDL-C levels in Chinese Taiwanese [32]. A study of
women with hyperalphalipoproteinemia also showed
that SCARB1 protein was inversely correlated with
HDL-C levels and HDL size [33], which suggesting that
the SCARB1 in human may partly play the similar role
Table 4 Correlative factors for serum lipid parameters between males and females
Lipid parameter Relative factor Unstandardized coefficient Std. error Standardized coefficient t P
Bai Ku Yao/male
TC Body mass index 0.120 0.028 0.245 4.268 0.000
TG Body mass index 0.112 0.033 0.200 3.436 0.001
HDL-C Alcohol consumption 0.192 0.036 0.304 5.274 0.000
Age 0.006 0.002 0.189 3.302 0.001
Genotype −0.416 0.137 −0.166 −3.036 0.003
Body mass index −0.026 0.012 −0.116 −2.116 0.035
LDL-C Body mass index 0.098 0.024 0.236 4.092 0.000
ApoAI Alcohol consumption 0.170 0.028 0.342 6.048 0.000
Age 0.004 0.001 0.155 2.743 0.006
Genotype −0.287 0.107 −0.145 −2.690 0.008
ApoB Body mass index 0.029 0.006 0.267 4.677 0.000
ApoAI/ApoB Alcohol consumption 0.376 0.071 0.301 5.274 0.000
Body mass index −0.069 0.025 −0.157 −2.752 0.006
Bai Ku Yao/female
TC Systolic blood pressure 0.007 0.003 0.145 2.602 0.010
Body mass index 0.036 0.017 0.120 2.138 0.033
Genotype 0.165 0.078 0.118 2.118 0.035
TG Alcohol consumption 0.311 0.079 0.219 3.961 0.000
LDL-C Genotype 0.151 0.061 0.135 2.465 0.014
Body mass index 0.034 0.014 0.141 2.519 0.012
Age 0.005 0.003 0.122 1.997 0.047
ApoAI Age 0.002 0.001 0.141 2.509 0.013
ApoB Systolic blood pressure 0.002 0.001 0.175 3.134 0.002
Body mass index 0.012 0.005 0.143 2.572 0.011
ApoAI/ApoB Diastolic blood pressure −0.007 0.003 −0.139 −2.466 0.014
Han/male
TC Diastolic blood pressure 0.019 0.005 0.227 3.783 0.000
Age 0.013 0.003 0.239 4.243 0.000
Alcohol consumption 0.249 0.071 0.186 3.494 0.001
Body mass index 0.031 0.015 0.120 2.108 0.036
TG Body mass index 0.119 0.021 0.320 5.729 0.000
Cigarette smoking 0.282 0.092 0.172 3.069 0.002
Genotype 0.292 0.132 0.125 2.216 0.027
HDL-C Alcohol consumption 0.177 0.034 0.287 5.223 0.000
Age 0.006 0.001 0.237 4.082 0.000
Body mass index −0.029 0.007 −0.243 −4.147 0.000
Diastolic blood pressure 0.006 0.002 0.156 2.523 0.012
Genotype −0.082 0.041 −0.108 −2.011 0.045
LDL-C Age 0.009 0.003 0.210 3.450 0.001
Diastolic blood pressure 0.009 0.004 0.142 2.181 0.030
Body mass index 0.026 0.013 0.128 2.082 0.038
ApoAI Alcohol consumption 0.161 0.023 0.369 6.960 0.000
Age 0.005 0.001 0.281 5.301 0.000
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Table 4 Correlative factors for serum lipid parameters between males and females (Continued)
ApoB Body mass index 0.015 0.003 0.283 5.122 0.000
Age 0.003 0.001 0.245 4.418 0.000
Alcohol consumption 0.035 0.015 0.132 2.384 0.018
ApoAI/ApoB Body mass index −0.036 0.008 −0.272 −4.721 0.000
Alcohol consumption 0.161 0.039 0.240 4.150 0.000
Han/female
TC Age 0.020 0.004 0.292 5.413 0.000
Body mass index 0.074 0.017 0.232 4.308 0.000
TG Body mass index 0.057 0.016 0.196 3.499 0.001
HDL-C Cigarette smoking 0.479 0.198 0.137 2.425 0.016
LDL-C Age 0.016 0.003 0.299 5.612 0.000
Body mass index 0.066 0.014 0.254 4.769 0.000
ApoAI Age 0.004 0.001 0.209 3.761 0.000
Cigarette smoking 0.316 0.124 0.142 2.559 0.011
ApoB Body mass index 0.022 0.003 0.344 6.530 0.000
Age 0.003 0.001 0.223 4.228 0.000
ApoAI/ApoB Body mass index −0.042 0.010 −0.236 −4.335 0.000
Cigarette smoking 0.883 0.232 0.207 3.810 0.000
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B.
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reported that the rs5888 variant in the SCARB1 affected
SCARB1 RNA secondary structure, protein translation,
and was significantly associated with reduced SCARB1
protein expression and function in vitro [34]. In the
present research, however, we showed that the subjects
with TT genotype in Bai Ku Yao had lower HDL-C and
ApoAI levels in males than the subjects with CC or CT
genotype, and the T allele carriers had higher TC,
LDL-C and ApoB levels in females than the T allele non-
carriers. The participants with TT genotype in Han also
had a lower tendency of HDL-C and ApoAI levels in
males than the participants with CC or CT genotype,
but the difference did not reach statistically significant.
The association of serum HDL-C and ApoAI levels and
genotypes was confirmed by the multiple linear regres-
sion analysis in both ethnic groups. It is difficult to ex-
plain these contradictory findings. The possible reasons
may be as follows. Firstly, in our study the frequency of
C allele was 78.3% in Bai Ku Yao and 73.7% in Han. In
white populations, however, the C allelic frequency of
SCARB1 rs5888 was varied from 40% to 60%, which sug-
gests that our study populations had different genetic
background from white populations. Moreover, the C-T
change at exon 8 did not affect the amino acid sequence
of the protein, the SNP might be in linkage disequilib-
rium with a functional mutation in the SCARB1 gene, or
alternatively with another nearby functional variant at
the chromosomal region of 12q24 where several othercandidate genes involved in lipid metabolism have been
localized (i.e. ACACB, PLA2, CLTA, MVK-MMAB,
ACADS, and TCF1) [20,23]. Thus, our findings contra-
dict with previous papers may attribute to different func-
tional mutation of the SCARB1 rs5888 or to be in
linkage disequibibrium with other SNPs. Secondly, it
might because of difference in study designs, sample
size, as well as gene-enviromental interactions. Lastly,
the size of our study population is a bit small, and the
number of subjects with TT genotype in both ethnic
groups is also small, which might not have had the
power to detect the association of TT genotype and
serum lipid levels.
In addition to the influence of genetic factors, environ-
mental factors also play an important role in determin-
ing serum lipid levels [25,26] . In the present study, we
also found that serum lipid parameters were correlated
with several environmental factors. Although Bai Ku Yao
and Han reside in the same region, the diet and lifestyle
were significant difference between the two ethnic
groups. For the Bai Ku Yao population, corn was the
staple food and rice, soy, buckwheat, sweet potato, and
pumpkin products were the subsidiary foods. Approxi-
mately 90% of the beverages were corn wine and rum.
The alcohol content is about 15% (v/v). They are also
accustomed to drink Hempseed soup. In contrast, rice
was the staple food and corn, broomcorn, potato, and
taro products were the subsidiary foods in the Han
population. About 90% of the beverage was rice wine.
Table 5 Correlative factors for serum lipid parameters
Lipid parameter Relative factor Unstandardized coefficient Std. error Standardized coefficient t P
Both Yao and Han
TC Age 0.011 0.002 0.181 6.402 0.000
Body mass index 0.059 0.009 0.180 6.419 0.000
Ethnic group 0.343 0.054 0.177 6.368 0.000
Diastolic blood pressure 0.010 0.003 0.115 3.850 0.000
Alcohol consumption 0.089 0.039 0.064 2.285 0.022
TG Body mass index 0.078 0.010 0.211 7.567 0.000
Sex −0.257 0.071 −0.117 −3.631 0.000
Alcohol consumption 0.207 0.052 0.133 3.981 0.000
Ethnic group 0.167 0.063 0.076 2.657 0.008
HDL-C Age 0.005 0.001 0.174 6.163 0.000
Alcohol consumption 0.172 0.021 0.275 8.177 0.000
Sex 0.155 0.029 0.176 5.435 0.000
Ethnic group 0.115 0.025 0.130 4.548 0.000
Body mass index −0.018 0.004 −0.119 −4.252 0.000
Genotype −0.049 0.020 −0.066 −2.389 0.017
LDL-C Body mass index 0.051 0.008 0.193 6.678 0.000
Age 0.008 0.001 0.167 5.731 0.000
Ethnic group 0.103 0.045 0.066 2.313 0.021
Diastolic blood pressure 0.007 0.002 0.089 2.894 0.004
Alcohol consumption −0.065 0.032 −0.059 −2.029 0.043
ApoAI Alcohol consumption 0.156 0.015 0.346 10.638 0.000
Age 0.004 0.001 0.194 7.111 0.000
Ethnic group 0.086 0.018 0.136 4.852 0.000
Genotype −0.132 0.039 −0.092 −3.420 0.001
Sex 0.065 0.020 0.103 3.285 0.001
ApoB Body mass index 0.018 0.002 0.249 8.686 0.000
Age 0.002 0.000 0.148 5.150 0.000
Ethnic group −0.038 0.012 −0.089 −3.237 0.001
Diastolic blood pressure 0.002 0.001 0.080 2.669 0.008
ApoAI/ApoB Alcohol consumption 0.267 0.031 0.286 8.523 0.000
Body mass index −0.042 0.006 −0.190 −6.777 0.000
Ethnic group 0.142 0.038 0.108 3.755 0.000
Sex 0.105 0.043 0.080 2.458 0.014
Bai Ku Yao
TC Body mass index 0.067 0.016 0.172 4.214 0.000
Age 0.007 0.002 0.109 2.655 0.008
Diastolic blood pressure 0.008 0.004 0.083 1.972 0.049
TG Alcohol consumption 0.258 0.067 0.198 3.872 0.000
Body mass index 0.054 0.016 0.132 3.302 0.001
Sex −0.330 0.106 −0.169 −3.116 0.002
Cigarette smoking −0.153 0.070 −0.120 −2.185 0.029
HDL-C Alcohol consumption 0.126 0.022 0.228 5.777 0.000
Age 0.004 0.001 0.142 3.586 0.000
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Table 5 Correlative factors for serum lipid parameters (Continued)
Genotype −0.245 0.090 −0.106 −2.714 0.007
LDL-C Body mass index 0.062 0.013 0.194 4.855 0.000
Age 0.005 0.002 0.098 2.437 0.015
ApoAI Alcohol consumption 0.143 0.016 0.333 8.708 0.000
Age 0.003 0.001 0.140 3.655 0.000
Genotype −0.177 0.068 −0.099 −2.611 0.009
ApoB Body mass index 0.019 0.004 0.205 5.064 0.000
Age 0.002 0.001 0.104 2.564 0.011
Alcohol consumption −0.032 0.012 −0.107 −2.611 0.009
Diastolic blood pressure 0.002 0.001 0.097 2.306 0.021
ApoAI/ApoB Alcohol consumption 0.311 0.039 0.309 7.940 0.000
Body mass index −0.044 0.012 −0.137 −3.522 0.000
Han Chinese
TC Age 0.016 0.002 0.260 6.443 0.000
Body mass index 0.050 0.011 0.174 4.374 0.000
Diastolic blood pressure 0.012 0.004 0.142 3.341 0.001
Alcohol consumption 0.164 0.061 0.101 2.697 0.007
TG Body mass index 0.094 0.013 0.270 6.949 0.000
Cigarette smoking 0.357 0.063 0.221 5.697 0.000
HDL-C Age 0.006 0.001 0.219 5.533 0.000
Sex 0.244 0.040 0.264 6.074 0.000
Alcohol consumption 0.190 0.033 0.250 5.702 0.000
Body mass index −0.022 0.005 −0.163 −4.119 0.000
Genotype −0.075 0.028 −0.101 −2.635 0.009
LDL-C Age 0.012 0.002 0.245 5.873 0.000
Body mass index 0.043 0.009 0.186 4.533 0.000
Diastolic blood pressure 0.006 0.003 0.090 2.062 0.040
ApoAI Age 0.005 0.001 0.251 6.600 0.000
Alcohol consumption 0.165 0.022 0.326 7.621 0.000
Sex 0.134 0.026 0.217 5.096 0.000
Genotype −0.037 0.019 −0.074 −1.979 0.048
ApoB Body mass index 0.018 0.002 0.323 8.524 0.000
Age 0.003 0.000 0.228 5.967 0.000
Cigarette smoking 0.028 0.010 0.105 2.807 0.005
ApoAI/ApoB Body mass index −0.039 0.006 −0.256 −6.450 0.000
Sex 0.232 0.047 0.218 4.931 0.000
Alcohol consumption 0.184 0.039 0.211 4.724 0.000
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B.
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ences in diet and lifestyle could partly account for the
differences in serum lipid profiles between the two eth-
nic groups. Corn contains abundant dietary fiber and
plant protein [35]. Consumption of dietary fiber, specif-
ically the soluble type, such as pectins and guar gum candecrease serum TC levels [36,37]. Plant protein might
promote the transportation and excretion of free choles-
terol. Dietary soy protein has well-documented beneficial
effects on serum lipid concentrations [38,39]. Buckwheat
protein products have a potent hypocholesterolemic ac-
tivity [40,41]. Ludvik et al. [42] found that ingestion of
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tato) for 6 weeks reduced TC and LDL-C in type 2 dia-
betic patients previously treated by diet alone. Studies
have demonstrated that pumpkin is a useful therapy for
hypercholesterolemia through reducing oxidative stress
and cholesterol levels [43]. There are more than 29 fat
soluble constituents in Hempseed, among which satu-
rated and unsaturated fatty acid methyl esters account
for 12.36% and 86.96%; respectively [44]. Previous ex-
perimental and clinical studies have demonstrated that
Hempseed or Hempseed oil can decrease TC, TG and
LDL-C levels, reduce atherogenic index, and increase
HDL-C concentration [25,26,45].
Conclusion
The present study shows that the frequency of T allele
of SCARB1 rs5888 SNP is lower in Bai Ku Yao than in
Han Chinese. The subjects with TT genotype in Bai Ku
Yao had lower HDL-C and ApoAI levels in males than
the subjects with CC or CT genotype, and the T allele
carriers had higher TC, LDL-C and ApoB levels in
females than the T allele noncarriers. The participants
with TT genotype in Han also had a lower tendency of
HDL-C and ApoAI levels in males than the participants
with CC or CT genotype, but the difference did not
reach statistically significant. The levels of HDL-C and
ApoAI were correlated with genotypes in the both eth-
nic groups. These results suggest that the differences in
serum lipid levels between the two enthnic groups might
partially attribute to the differences in the SCARB1
rs5888 SNP and several environmental factors.
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